ClinicalTrials.gg
Drug

Irosustat clinical trials

Also written BN83495 and STX64.

studies test it
7
open now
0
in phase 3
0
first study started
2007

How each study uses irosustat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Irosustat
2

Development codes

BN83495
5
STX64
2
667 Coumate
2

Studies by the year they started

7 studies that test it; most in 2009 (2)

Studies that test irosustat, by start year
YearStudies
20071
20092
20101
20111
20122

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
5

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 5 · Other 2

Ipsen (5) · Imperial College London (2)

Studies

Open first, then newest update. How each study uses irosustat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 7

Codes

What other systems call irosustat · ClinicalTrials.gg INT005099

  • MeSH (NLM) C520511irosustatOne source NLM
  • UNII (FDA) 366037O6O7IROSUSTATConfirmed FDA, NLM, Wikidata
  • Wikidata Q27093313irosustatConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C79827IrosustatOne source FDA
  • DrugBank DB02292One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.